- Home
- VNO vs ACHC Comparison
VNO vs ACHC Comparison
Compare VNO & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNO
- ACHC
- Stock Information
- Founded
- VNO 1946
- ACHC 2005
- Country
- VNO United States
- ACHC United States
- Employees
- VNO N/A
- ACHC N/A
- Industry
- VNO Real Estate Investment Trusts
- ACHC Medical Specialities
- Sector
- VNO Real Estate
- ACHC Health Care
- Exchange
- VNO Nasdaq
- ACHC Nasdaq
- Market Cap
- VNO 7.0B
- ACHC 2.1B
- IPO Year
- VNO N/A
- ACHC N/A
- Fundamental
- Price
- VNO $39.13
- ACHC $25.72
- Analyst Decision
- VNO Hold
- ACHC Strong Buy
- Analyst Count
- VNO 11
- ACHC 10
- Target Price
- VNO $38.00
- ACHC $52.25
- AVG Volume (30 Days)
- VNO 1.3M
- ACHC 3.6M
- Earning Date
- VNO 05-05-2025
- ACHC 05-12-2025
- Dividend Yield
- VNO 1.90%
- ACHC N/A
- EPS Growth
- VNO 248.25
- ACHC N/A
- EPS
- VNO 0.52
- ACHC 2.04
- Revenue
- VNO $1,929,890,000.00
- ACHC $3,156,417,000.00
- Revenue This Year
- VNO N/A
- ACHC $7.90
- Revenue Next Year
- VNO $5.12
- ACHC $8.58
- P/E Ratio
- VNO $74.18
- ACHC $12.60
- Revenue Growth
- VNO 2.98
- ACHC 5.48
- 52 Week Low
- VNO $22.42
- ACHC $20.36
- 52 Week High
- VNO $46.63
- ACHC $82.41
- Technical
- Relative Strength Index (RSI)
- VNO 59.91
- ACHC 53.03
- Support Level
- VNO $38.45
- ACHC $23.83
- Resistance Level
- VNO $40.73
- ACHC $28.48
- Average True Range (ATR)
- VNO 1.21
- ACHC 1.29
- MACD
- VNO 0.46
- ACHC 0.71
- Stochastic Oscillator
- VNO 77.01
- ACHC 61.56
About VNO Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.